Exodus Point Capital Management, LP Harrow Health, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 61,100 shares of HROW stock, worth $1.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
61,100
Previous 34,099
79.18%
Holding current value
$1.35 Million
Previous $490,000
64.9%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HROW
# of Institutions
124Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$86.7 Million12.62% of portfolio
-
Private Capital Management, LLC Naples, FL3.01MShares$66.6 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$48.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$40.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$21.1 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $599M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...